Vela Diagnostics to Include ZIKA Virus Test in the Sentosa® Tropical Infections Panel

By Vela Diagnostics

Genomeweb/ Singapore (January 27, 2016) – Vela Diagnostics announced today the expansion of Sentosa® Tropical Infections Panel with the addition of ZIKA Virus RT-PCR Test to the product pipeline.

Vela’s ZIKA Virus RT-PCR test is to be used on the Sentosa PCR workflow in conjunction with Vela’s Tropical IVD panel currently including Dengue and Chikungunya Virus.

Dr. Gerd Michel, Chief Technology Officer of Vela Diagnostics, commented that, “Zika is a pandemic in rapid progress, and many important questions about it, remain to be answered. With Vela’s expertise in molecular diagnostics for a broad portfolio of viral diseases, including dengue and chikungunya, we are well positioned to add yet another PCR assay for a vector borne infection like Zika. With such an assay at hand we can make a significant contribution towards better understanding and fighting the emerging spread of the virus."

Vela Diagnostics has launched the CE-IVD Sentosa® SA Chikungunya RT-PCR Test and Sentosa® Dengue I-IV RT-PCR Test as part of the Tropical Infections Panel. With the addition of ZIKA Virus RT-PCR Test to the existing panel, Vela strives to provide a comprehensive solution to meet customers’ clinical and laboratory needs in managing Tropical infections.

As part of the clinical validation studies, Vela will provide Zika virus primer/probe sequences, positive control and other reagents to collaborators who are keen to test the currently Research Use Only Zika Virus test.

 

To inquire more on evaluation collaboration or clinical validation studies, please contact Global Product Management, gpm@veladx.com.

Learn more about Sentosa® SA CHIKV RT-PCR Test here and Sentosa® Dengue PCR Test here.

*Product availability dependent on local regulatory approvals

Go back